Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4337670 | 1.00 | LMNA (0.38) | LMNATHRB | |
| SCHEMBL25685789 | 1.00 | LMNA (0.38) | LMNATHRB | |
| SCHEMBL20848204 | 1.00 | LMNA (0.38) | LMNATHRB | |
| SCHEMBL4337634 | 1.00 | LMNA (0.38) | LMNATHRB | |
| SCHEMBL28597147 | 0.97 | LMNA (0.33) | LMNA | |
| SCHEMBL4182547 | 0.87 | — | — | |
| SCHEMBL10300018 | 0.87 | — | — | |
| SCHEMBL25685341 | 0.80 | — | — | |
| SCHEMBL3022678 | 0.79 | — | — | |
| SCHEMBL14780804 | 0.78 | LMNA (0.32) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113134210-A | Fire extinguishing article and method for manufacturing same | 南京同宁新材料研究院有限公司 | 2021-07-20 | — | — | CN | claimed |
| EP-0614874-B1 | Process for the preparation of halogenated esters of carboxylic or dicarboxylic acids | ATOCHEM ELF SA (FR) | 1999-01-27 | — | — | EP | claimed |
| WO-2023119165-A1 | COMPOUNDS COMPRISING A PLURALITY OF SILSESQUIOXANE GROUPS FOR FORMING A PATTERNING COATING AND DEVICES INCORPORATING SAME | OTI LUMIONICS INC. (CA) | 2023-06-29 | — | — | WO | disclosed |
| CN-115872833-A | Synthesis method of deuterated perfluorohexyl n-octane | 江苏正大清江制药有限公司 | 2023-03-31 | — | — | CN | disclosed |
| CN-115703693-A | Novel synthesis method of perfluorohexyl n-octane | 江苏正大清江制药有限公司 | 2023-02-17 | — | — | CN | disclosed |
| EP-3645634-B1 | FLUORINATED ESTER COMPOUND ADDITIVES FOR ARCHITECTURAL COATINGS | CHEMOURS CO FC LLC (US) | 2022-12-28 | — | — | EP | disclosed |
| US-11518894-B2 | Fluorinated ester compound additives for architectural coatings | THE CHEMOURS COMPANY FC, LLC (US) | 2022-12-06 | — | — | US | disclosed |
| WO-2022097043-A1 | SILICON-CONTAINING COMPOUNDS FOR FORMING A PATTERNING COATING AND DEVICES INCORPORATING SAME | OTI LUMIONICS INC. (CA) | 2022-05-12 | — | — | WO | disclosed |
| CN-113134210-A | Fire extinguishing article and method for manufacturing same | 南京同宁新材料研究院有限公司 | 2021-07-20 | — | — | CN | disclosed |
| EP-3269395-A1 | AMINOALCOHOL LIPIDOIDS AND USES THEREOF | Massachusetts Institute Of Technology (US) | 2018-01-17 | — | — | EP | disclosed |
| EP-2389399-A2 | FUNCTIONALIZED POLYURETHANE RESIN, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF | Construction Research & Technology GmbH (DE) | 2011-11-30 | — | — | EP | disclosed |
| US-20090198000-A1 | Liquid fluorine-containing and two-component compositions for the surface treatment of mineral and non-mineral substrates | EVONIK DEGUSSA GMBH (DE) | 2009-08-06 | — | — | US | disclosed |
| EP-2085442-A1 | Compounds containing fluoride with improved surface characteristics | Evonik Degussa GmbH (DE) | 2009-08-05 | — | — | EP | disclosed |
| US-20090054588-A1 | Fluoride-modified additive for cementitious products, process for its preparation and use thereof | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2009-02-26 | — | — | US | disclosed |
| WO-2008040428-A2 | FUNCTIONALIZED POLYURETHANE RESIN, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2008-04-10 | — | — | WO | disclosed |
| US-6780855-B2 | TREATING A PATIENT SUFFERING FROM AN ESTROGEN DEPENDENT-DISEASE | SCHERING AKTIENGESELLSCHAFT (DE) | 2004-08-24 | — | — | US | disclosed |
| US-20030069434-A1 | 11BETA-HALOGEN-7ALPHA-SUBSTITUTED ESTRATRIENES, METOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11BETA-HALOGEN-7ALPHA- SUBSTITUTED ESTRATRIENES AND USE OF THE SAME FOR PRODUCING MEDICAMENTS | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2003-04-10 | — | — | US | disclosed |
| EP-1042355-B1 | 11BETA-HALOGEN-7ALPHA-SUBSTITUTED ESTRATRIENES, METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11BETA-HALOGEN-7ALPHA-SUBSTITUTED ESTRATRIENES AND USE OF THE SAME FOR PRODUCING MEDICAMENTS | SCHERING AG (DE) | 2003-02-12 | — | — | EP | disclosed |
| EP-1042355-A1 | 11BETA-HALOGEN-7ALPHA-SUBSTITUTED ESTRATRIENES, METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11BETA-HALOGEN-7ALPHA-SUBSTITUTED ESTRATRIENES AND USE OF THE SAME FOR PRODUCING MEDICAMENTS | Schering Aktiengesellschaft (DE) | 2000-10-11 | — | — | EP | disclosed |
| WO-1999033855-A1 | 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES, METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES AND USE OF THE SAME FOR PRODUCING MEDICAMENTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1999-07-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030069434-A1 | 11BETA-HALOGEN-7ALPHA-SUBSTITUTED ESTRATRIENES, METOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11BETA-HALOGEN-7ALPHA- SUBSTITUTED ESTRATRIENES AND USE OF THE SAME FOR PRODUCING MEDICAMENTS | CYP19A1, HSD17B11, NR5A1 | LMNA 4408/4885THRB 254/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.